1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Global Lung Cancer Therapeutics Industry 2015 Market Research Report

Summary


The Global Lung Cancer Therapeutics Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Lung Cancer Therapeutics industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Lung Cancer Therapeutics market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out.The Lung Cancer Therapeutics industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 270 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table Of Contents

Global Lung Cancer Therapeutics Industry 2015 Market Research Report
Table of Contents

1 Industry Overview
1.1 Definition and Specifications of Lung Cancer Therapeutics
1.2 Classification of Lung Cancer Therapeutics
1.3 Applications of Lung Cancer Therapeutics
1.4 Industry Chain Structure of Lung Cancer Therapeutics
1.5 Industry Regional Overview of Lung Cancer Therapeutics
1.6 Industry Policy Analysis of Lung Cancer Therapeutics
1.7 Industry News Analysis of Lung Cancer Therapeutics

2 Manufacturing Cost Structure Analysis of Lung Cancer Therapeutics
2.1 Raw Material Suppliers and Price Analysis of Lung Cancer Therapeutics
2.2 Equipment Suppliers and Price Analysis of Lung Cancer Therapeutics
2.3 Labor Cost Analysis of Lung Cancer Therapeutics
2.4 Other Costs Analysis of Lung Cancer Therapeutics
2.5 Manufacturing Cost Structure Analysis of Lung Cancer Therapeutics
2.6 Manufacturing Process Analysis of Lung Cancer Therapeutics

3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of Global Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of Global Key Lung Cancer Therapeutics Manufacturers in 2014
3.3 RandD Status and Technology Source of Global Lung Cancer Therapeutics Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of Global Lung Cancer Therapeutics Key Manufacturers in 2014

4 Production Analysis of Lung Cancer Therapeutics by Regions, Technology, and Applications
4.1 Global Production of Lung Cancer Therapeutics by Regions (US, EU, China, Japan, etc.) 2010-2015
4.2 Global Production of Lung Cancer Therapeutics by Technology 2010-2015
4.3 Global Production of Lung Cancer Therapeutics by Applications 2010-2015
4.4 Price Analysis of Global Lung Cancer Therapeutics Key Manufacturers in 2015
4.5 US Capacity, Production, Price, Cost and Revenue of Lung Cancer Therapeutics 2010-2015
4.6 EU Capacity, Production, Price, Cost and Revenue of Lung Cancer Therapeutics 2010-2015
4.7 Japan Capacity, Production, Price, Cost and Revenue of Lung Cancer Therapeutics 2010-2015
4.8 China Capacity, Production, Price, Cost and Revenue of Lung Cancer Therapeutics 2010-2015
4.9 US Supply, Import, Export and Consumption of Lung Cancer Therapeutics 2010-2015
4.10 EU Supply, Import, Export and Consumption of Lung Cancer Therapeutics 2010-2015
4.11 Japan Supply, Import, Export and Consumption of Lung Cancer Therapeutics 2010-2015
4.12 China Supply, Import, Export and Consumption of Lung Cancer Therapeutics 2010-2015

5 Sales and Revenue Analysis of Lung Cancer Therapeutics by Regions
5.1 Global Sales of Lung Cancer Therapeutics by Regions (US, EU, China, Japan, etc.) 2010-2015
5.2 Global Revenue of Lung Cancer Therapeutics by Regions (US, EU, China, Japan, etc.) 2010-2015
5.3 Global Price Analysis of Lung Cancer Therapeutics Sales by Regions (US, EU, China, Japan, etc.) 2010-2015
5.4 Global Price, Cost and Gross of Lung Cancer Therapeutics 2010-2015

6 Analysis of Lung Cancer Therapeutics Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity and Production of Lung Cancer Therapeutics 2010-2015
6.2 Production Market Share Analysis of Lung Cancer Therapeutics 2010-2015
6.3 Sales Overview of Lung Cancer Therapeutics 2010-2015
6.4 Supply, Sales and Shortage of Lung Cancer Therapeutics 2010-2015
6.5 Import, Export and Consumption of Lung Cancer Therapeutics 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Lung Cancer Therapeutics 2010-2015

7 Analysis of Lung Cancer Therapeutics Industry Key Manufacturers
7.1 AstraZeneca
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity Production Price Cost Production Value
7.1.4 Contact Information

7.2 Celgene
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity Production Price Cost Production Value
7.2.4 Contact Information

7.3 Eli Lilly
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity Production Price Cost Production Value
7.3.4 Contact Information

7.4 F. Hoffmann-La Roche
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity Production Price Cost Production Value
7.4.4 Contact Information

7.5 Pfizer
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity Production Price Cost Production Value
7.5.4 Contact Information

7.6 Abbvie
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity Production Price Cost Production Value
7.6.4 Contact Information

7.7 Aetna
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity Production Price Cost Production Value
7.7.4 Contact Information

7.8 Agennix
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity Production Price Cost Production Value
7.8.4 Contact Information

7.9 Amgen
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity Production Price Cost Production Value
7.9.4 Contact Information

7.10 Boehringer Ingelheim
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity Production Price Cost Production Value
7.10.4 Contact Information

7.11 Celldex
7.11.1 Company Profile
7.11.2 Product Picture and Specification
7.11.3 Capacity Production Price Cost Production Value
7.11.4 Contact Information

7.12 Eisai
7.12.1 Company Profile
7.12.2 Product Picture and Specification
7.12.3 Capacity Production Price Cost Production Value
7.12.4 Contact Information

7.13 GlaxoSmithKline
7.13.1 Company Profile
7.13.2 Product Picture and Specification
7.13.3 Capacity Production Price Cost Production Value
7.13.4 Contact Information

7.14 GTx
7.14.1 Company Profile
7.14.2 Product Picture and Specification
7.14.3 Capacity Production Price Cost Production Value
7.14.4 Contact Information

7.15 Helsinn
7.15.1 Company Profile
7.15.2 Product Picture and Specification
7.15.3 Capacity Production Price Cost Production Value
7.15.4 Contact Information

7.16 IMClone
7.16.1 Company Profile
7.16.2 Product Picture and Specification
7.16.3 Capacity Production Price Cost Production Value
7.16.4 Contact Information

7.17 Merck Serono
7.17.1 Company Profile
7.17.2 Product Picture and Specification
7.17.3 Capacity Production Price Cost Production Value
7.17.4 Contact Information

7.18 Novartis
7.18.1 Company Profile
7.18.2 Product Picture and Specification
7.18.3 Capacity Production Price Cost Production Value
7.18.4 Contact Information

7.19 Qiagen
7.19.1 Company Profile
7.19.2 Product Picture and Specification
7.19.3 Capacity Production Price Cost Production Value
7.19.4 Contact Information

7.20 OncoGenex
7.20.1 Company Profile
7.20.2 Product Picture and Specification
7.20.3 Capacity Production Price Cost Production Value
7.20.4 Contact Information

7.21 OSI Pharmaceuticals
7.21.1 Company Profile
7.21.2 Product Picture and Specification
7.21.3 Capacity Production Price Cost Production Value
7.21.4 Contact Information

7.22 Peregrine
7.22.1 Company Profile
7.22.2 Product Picture and Specification
7.22.3 Capacity Production Price Cost Production Value
7.22.4 Contact Information

7.23 Pierre Fabre
7.23.1 Company Profile
7.23.2 Product Picture and Specification
7.23.3 Capacity Production Price Cost Production Value
7.23.4 Contact Information

7.24 Sanofi
7.24.1 Company Profile
7.24.2 Product Picture and Specification
7.24.3 Capacity Production Price Cost Production Value
7.24.4 Contact Information

7.25 Synta
7.25.1 Company Profile
7.25.2 Product Picture and Specification
7.25.3 Capacity Production Price Cost Production Value
7.25.4 Contact Information

7.26 Telik
7.26.1 Company Profile
7.26.2 Product Picture and Specification
7.26.3 Capacity Production Price Cost Production Value
7.26.4 Contact Information

7.27 Teva Pharmaceutical
7.27.1 Company Profile
7.27.2 Product Picture and Specification
7.27.3 Capacity Production Price Cost Production Value
7.27.4 Contact Information

8 Price and Gross Margin Analysis
8.1 Analysis of Price, Supply and Consumption
8.1.1 Price Analysis
8.1.2 Supply Analysis
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Lung Cancer Therapeutics Product Types
8.5 Market Share Analysis of Different Lung Cancer Therapeutics Price Levels
8.6 Gross Margin Analysis of Different Lung Cancer Therapeutics Applications

9 Marketing Trader or Distributor Analysis of Lung Cancer Therapeutics
9.1 Marketing Channels Status of Lung Cancer Therapeutics
9.2 Traders or Distributors of Lung Cancer Therapeutics with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Lung Cancer Therapeutics
9.4 Regional Import, Export and Trade Analysis of Lung Cancer Therapeutics

10 Development Trend of Lung Cancer Therapeutics Industry 2015-2020
10.1 Capacity and Production Overview of Lung Cancer Therapeutics 2015-2020
10.2 Production Market Share Analysis of Lung Cancer Therapeutics 2015-2020
10.3 Sales Overview of Lung Cancer Therapeutics 2015-2020
10.4 Supply, Sales, and Shortage of Lung Cancer Therapeutics 2015-2020
10.5 Import, Export and Consumption of Lung Cancer Therapeutics 2015-2020
10.6 Cost, Price, Revenue and Gross Margin of Lung Cancer Therapeutics 2015-2020

11 Industry Chain Suppliers of Lung Cancer Therapeutics with Contact Information
11.1 Major Raw Materials Suppliers of Lung Cancer Therapeutics with Contact Information
11.2 Manufacturing Equipment Suppliers of Lung Cancer Therapeutics with Contact Information
11.3 Major Suppliers of Lung Cancer Therapeutics with Contact Information
11.4 Key Consumers of Lung Cancer Therapeutics with Contact Information
11.5 Supply Chain Relationship Analysis of Lung Cancer Therapeutics

12 New Project Investment Feasibility Analysis of Lung Cancer Therapeutics
12.1 New Project SWOT Analysis of Lung Cancer Therapeutics
12.2 New Project Investment Feasibility Analysis of Lung Cancer Therapeutics

13 Conclusion of the Global Lung Cancer Therapeutics Industry 2015 Market Research Report




List of Tables and Figures
Figure Picture of Lung Cancer Therapeutics
Table Product Specifications of Lung Cancer Therapeutics
Figure Global Sales Market Share of Lung Cancer Therapeutics by Product Types in 2014
Figure Global Sales Market Share of Lung Cancer Therapeutics by Applications in 2014
Figure Industry Chain Structure of Lung Cancer Therapeutics
Table Global Major Lung Cancer Therapeutics Manufacturers
Table Industry Policy of Lung Cancer Therapeutics
Table Industry News List of Lung Cancer Therapeutics
Table Manufacturing Cost Structure Analysis of Lung Cancer Therapeutics in 2014
Figure Manufacturing Process Analysis of Lung Cancer Therapeutics
Table Capacity (K Person-portion) and Commercial Production Date of Global Lung Cancer Therapeutics Key Manufacturers in 2014
Table Manufacturing Plants Distribution of Global Key Lung Cancer Therapeutics Manufacturers in 2014
Table RandD Status and Technology Source of Global Lung Cancer Therapeutics Key Manufacturers in 2014
Table Raw Materials Sources Analysis of Global and China Lung Cancer Therapeutics Key Manufacturers in 2014
Table Global Production of Lung Cancer Therapeutics by Regions 2010-2015 (K Person-portion)
Figure Global Production Market Share of Lung Cancer Therapeutics by Regions in 2010
Figure Global Production Market Share of Lung Cancer Therapeutics by Regions in 2011
Figure Global Production Market Share of Lung Cancer Therapeutics by Regions in 2012
Figure Global Production Market Share of Lung Cancer Therapeutics by Regions in 2013
Figure Global Production Market Share of Lung Cancer Therapeutics by Regions in 2014
Figure Global Production Market Share of Lung Cancer Therapeutics by Regions in 2015
Figure Global Production Market Share of Lung Cancer Therapeutics by Technology in 2010
Figure Global Production Market Share of Lung Cancer Therapeutics by Technology in 2011
Figure Global Production Market Share of Lung Cancer Therapeutics by Technology in 2012
Figure Global Production Market Share of Lung Cancer Therapeutics by Technology in 2013
Figure Global Production Market Share of Lung Cancer Therapeutics by Technology in 2014
Figure Global Production Market Share of Lung Cancer Therapeutics by Technology in 2015
Figure Global Production Market Share of Lung Cancer Therapeutics by Applications in 2010
Figure Global Production Market Share of Lung Cancer Therapeutics by Applications in 2011
Figure Global Production Market Share of Lung Cancer Therapeutics by Applications in 2012
Figure Global Production Market Share of Lung Cancer Therapeutics by Applications in 2013
Figure Global Production Market Share of Lung Cancer Therapeutics by Applications in 2014
Figure Global Production Market Share of Lung Cancer Therapeutics by Applications in 2015
Figure Price Comparison of Global Lung Cancer Therapeutics Key Manufacturers in 2015 (USD/Person-portion)
Table US Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion) and Revenue (M USD) of Lung Cancer Therapeutics 2010-2015
Table EU Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion) and Revenue (M USD) of Lung Cancer Therapeutics 2010-2015
Table Japan Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion) and Revenue (M USD) of Lung Cancer Therapeutics 2010-2015
Table China Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion) and Revenue (M USD) of Lung Cancer Therapeutics 2010-2015
Table US Supply, Import, Export and Consumption of Lung Cancer Therapeutics 2010-2015 (K Person-portion)
Table EU Supply, Import, Export and Consumption of Lung Cancer Therapeutics 2010-2015 (K Person-portion)
Table Japan Supply, Import, Export and Consumption of Lung Cancer Therapeutics 2010-2015 (K Person-portion)
Table China Supply, Import, Export and Consumption of Lung Cancer Therapeutics 2010-2015 (K Person-portion)
Table Global Sales of Lung Cancer Therapeutics by Regions (US, EU, China, Japan, etc.) 2010-2015 (K Person-portion)
Figure Global Sales of Lung Cancer Therapeutics by Regions (EU, China, Japan, etc.) in 2010 (K Person-portion)
Figure Global Sales of Lung Cancer Therapeutics by Regions (EU, China, Japan, etc.) in 2011 (K Person-portion)
Figure Global Sales of Lung Cancer Therapeutics by Regions (EU, China, Japan, etc.) in 2012 (K Person-portion)
Figure Global Sales of Lung Cancer Therapeutics by Regions (EU, China, Japan, etc.) in 2013 (K Person-portion)
Figure Global Sales of Lung Cancer Therapeutics by Regions (EU, China, Japan, etc.) in 2014 (K Person-portion)
Figure Global Sales of Lung Cancer Therapeutics by Regions (EU, China, Japan, etc.) in 2015 (K Person-portion)
Table Global Revenue of Lung Cancer Therapeutics by Regions (US, EU, China, Japan, etc.) 2010-2015 (M USD)
Figure Global Revenue of Lung Cancer Therapeutics by Regions (US, EU, China, Japan, etc.) in 2010 (M USD)
Figure Global Revenue of Lung Cancer Therapeutics by Regions (US, EU, China, Japan, etc.) in 2011 (M USD)
Figure Global Revenue of Lung Cancer Therapeutics by Regions (US, EU, China, Japan, etc.) in 2012 (M USD)
Figure Global Revenue of Lung Cancer Therapeutics by Regions (US, EU, China, Japan, etc.) in 2013 (M USD)
Figure Global Revenue of Lung Cancer Therapeutics by Regions (US, EU, China, Japan, etc.) in 2014 (M USD)
Figure Global Revenue of Lung Cancer Therapeutics by Regions (US, EU, China, Japan, etc.) in 2015 (M USD)
Table Sale Price of Lung Cancer Therapeutics by Regions (US, EU, China, Japan, etc.) 2010-2015 (USD/Person-portion)
Figure Global Price Analysis of Lung Cancer Therapeutics 2010-2015 (USD/Person-portion)
Figure Global Cost Analysis of Lung Cancer Therapeutics 2010-2015 (USD/Person-portion)
Figure Global Gross Analysis of Lung Cancer Therapeutics 2010-2015
Table Global and Major Manufacturers Capacity of Lung Cancer Therapeutics 2010-2015 (K Person-portion)
Table Global Capacity Market Share of Major Lung Cancer Therapeutics Manufacturers 2010-2015
Table Global and Major Manufacturers Production of Lung Cancer Therapeutics 2010-2015 (K Person-portion)
Table Global Production Market Share of Major Lung Cancer Therapeutics Manufacturers 2010-2015
Figure Global Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Lung Cancer Therapeutics 2010-2015
Figure Global Capacity Utilization Rate of Lung Cancer Therapeutics 2010-2015
Table Global and Major Manufacturers Revenue of Lung Cancer Therapeutics 2010-2015 (M USD)
Table Global Revenue Market Share of Major Lung Cancer Therapeutics Manufacturers 2010-2015
Figure Global Revenue (M USD) and Growth Rate of Lung Cancer Therapeutics 2010-2015
Table China and Major Manufacturers Capacity of Lung Cancer Therapeutics 2010-2015 (K Person-portion)
Table Capacity Market Share of China Major Lung Cancer Therapeutics Manufacturers 2010-2015
Table China and Major Manufacturers Production 2010-2015 (K Person-portion)
Table Production Market Share of China Major Manufacturers 2010-2015
Figure China Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Lung Cancer Therapeutics 2010-2015
Figure China Capacity Utilization Rate of Lung Cancer Therapeutics 2010-2015
Table China and Major Manufacturers Revenue of Lung Cancer Therapeutics 2010-2015 (M USD)
Table Revenue Market Share of China Major Manufacturers 2010-2015
Figure China Revenue (M USD) and Growth Rate of Lung Cancer Therapeutics 2010-2015
Figure Global Production Market Share of Major Lung Cancer Therapeutics Manufacturers in 2010
Figure Global Production Market Share of Major Lung Cancer Therapeutics Manufacturers in 2011
Figure Global Production Market Share of Major Lung Cancer Therapeutics Manufacturers in 2012
Figure Global Production Market Share of Major Lung Cancer Therapeutics Manufacturers in 2013
Figure Global Production Market Share of Major Lung Cancer Therapeutics Manufacturers in 2014
Figure Global Production Market Share of Major Lung Cancer Therapeutics Manufacturers in 2015
Figure China Production Market Share of Major Lung Cancer Therapeutics Manufacturers in 2010
Figure China Production Market Share of Major Lung Cancer Therapeutics Manufacturers in 2011
Figure China Production Market Share of Major Lung Cancer Therapeutics Manufacturers in 2012
Figure China Production Market Share of Major Lung Cancer Therapeutics Manufacturers in 2013
Figure China Production Market Share of Major Lung Cancer Therapeutics Manufacturers in 2014
Figure China Production Market Share of Major Lung Cancer Therapeutics Manufacturers in 2015
Figure Global Sales (K Person-portion) and Growth Rate of Lung Cancer Therapeutics 2010-2015
Figure China Sales (K Person-portion) and Growth Rate of Lung Cancer Therapeutics 2010-2015
Table Global Supply, Sales and Shortage of Lung Cancer Therapeutics 2010-2015 (K Person-portion)
Table China Supply, Sales and Shortage of Lung Cancer Therapeutics 2010-2015 (K Person-portion)
Table China Import, Export and Consumption of Lung Cancer Therapeutics 2010-2015 (K Person-portion)
Table Price of Global Lung Cancer Therapeutics Major Manufacturers 2010-2015 (USD/Person-portion)
Figure Price Comparison by Global Major Lung Cancer Therapeutics Manufacturers in 2014 (USD/Person-portion)
Table Gross Margin of Global Lung Cancer Therapeutics Major Manufacturers 2010-2015
Figure Gross Margin of Global Lung Cancer Therapeutics Major Manufacturers in 2014
Table Global and Major Manufacturers Revenue of Lung Cancer Therapeutics 2010-2015 (M USD)
Table Global Revenue Market Share of Major Lung Cancer Therapeutics Manufacturers 2010-2015
Figure Global Revenue Market Share of Major Lung Cancer Therapeutics Manufacturers in 2011
Figure Global Revenue Market Share of Major Lung Cancer Therapeutics Manufacturers in 2012
Figure Global Revenue Market Share of Major Lung Cancer Therapeutics Manufacturers in 2013
Figure Global Revenue Market Share of Major Lung Cancer Therapeutics Manufacturers in 2014
Figure Global Revenue Market Share of Major Lung Cancer Therapeutics Manufacturers in 2015
Table China and Major Manufacturers of Lung Cancer Therapeutics 2010-2015 (M USD)
Table Revenue Market Share of China Lung Cancer Therapeutics Major Manufacturers 2010-2015
Table Global Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Revenue (M USD) and Gross Margin of Lung Cancer Therapeutics 2010-2015
Table China Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Revenue (M USD) and Gross Margin of Lung Cancer Therapeutics 2010-2015
Figure AstraZeneca Lung Cancer Therapeutics Product Picture
Table AstraZeneca Lung Cancer Therapeutics Product Specification
Table 2010-2015 AstraZeneca Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 AstraZeneca Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 AstraZeneca Lung Cancer Therapeutics Product Production Global Market Share
Figure Celgene Lung Cancer Therapeutics Product Picture
Table Celgene Lung Cancer Therapeutics Product Specification
Table 2010-2015 Celgene Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Celgene Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Celgene Lung Cancer Therapeutics Product Production Global Market Share
Figure Eli Lilly Lung Cancer Therapeutics Product Picture
Table Eli Lilly Lung Cancer Therapeutics Product Specification
Table 2010-2015 Eli Lilly Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Eli Lilly Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Eli Lilly Lung Cancer Therapeutics Product Production Global Market Share
Figure F. Hoffmann-La Roche Lung Cancer Therapeutics Product Picture
Table F. Hoffmann-La Roche Lung Cancer Therapeutics Product Specification
Table 2010-2015 F. Hoffmann-La Roche Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 F. Hoffmann-La Roche Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 F. Hoffmann-La Roche Lung Cancer Therapeutics Product Production Global Market Share
Figure Pfizer Lung Cancer Therapeutics Product Picture
Table Pfizer Lung Cancer Therapeutics Product Specification
Table 2010-2015 Pfizer Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Pfizer Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Pfizer Lung Cancer Therapeutics Product Production Global Market Share
Figure Abbvie Lung Cancer Therapeutics Product Picture
Table Abbvie Lung Cancer Therapeutics Product Specification
Table 2010-2015 Abbvie Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Abbvie Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Abbvie Lung Cancer Therapeutics Product Production Global Market Share
Figure Aetna Lung Cancer Therapeutics Product Picture
Table Aetna Lung Cancer Therapeutics Product Specification
Table 2010-2015 Aetna Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Aetna Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Aetna Lung Cancer Therapeutics Product Production Global Market Share
Figure Agennix Lung Cancer Therapeutics Product Picture
Table Agennix Lung Cancer Therapeutics Product Specification
Table 2010-2015 Agennix Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Agennix Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Agennix Lung Cancer Therapeutics Product Production Global Market Share
Figure Amgen Lung Cancer Therapeutics Product Picture
Table Amgen Lung Cancer Therapeutics Product Specification
Table 2010-2015 Amgen Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Amgen Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Amgen Lung Cancer Therapeutics Product Production Global Market Share
Figure Boehringer Ingelheim Lung Cancer Therapeutics Product Picture
Table Boehringer Ingelheim Lung Cancer Therapeutics Product Specification
Table 2010-2015 Boehringer Ingelheim Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Boehringer Ingelheim Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Boehringer Ingelheim Lung Cancer Therapeutics Product Production Global Market Share
Figure Celldex Lung Cancer Therapeutics Product Picture
Table Celldex Lung Cancer Therapeutics Product Specification
Table 2010-2015 Celldex Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Celldex Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Celldex Lung Cancer Therapeutics Product Production Global Market Share
Figure Eisai Lung Cancer Therapeutics Product Picture
Table Eisai Lung Cancer Therapeutics Product Specification
Table 2010-2015 Eisai Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Eisai Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Eisai Lung Cancer Therapeutics Product Production Global Market Share
Figure GlaxoSmithKline Lung Cancer Therapeutics Product Picture
Table GlaxoSmithKline Lung Cancer Therapeutics Product Specification
Table 2010-2015 GlaxoSmithKline Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 GlaxoSmithKline Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 GlaxoSmithKline Lung Cancer Therapeutics Product Production Global Market Share
Figure GTx Lung Cancer Therapeutics Product Picture
Table GTx Lung Cancer Therapeutics Product Specification
Table 2010-2015 GTx Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 GTx Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 GTx Lung Cancer Therapeutics Product Production Global Market Share
Figure Helsinn Lung Cancer Therapeutics Product Picture
Table Helsinn Lung Cancer Therapeutics Product Specification
Table 2010-2015 Helsinn Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Helsinn Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Helsinn Lung Cancer Therapeutics Product Production Global Market Share
Figure IMClone Lung Cancer Therapeutics Product Picture
Table IMClone Lung Cancer Therapeutics Product Specification
Table 2010-2015 IMClone Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 IMClone Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 IMClone Lung Cancer Therapeutics Product Production Global Market Share
Figure Merck Serono Lung Cancer Therapeutics Product Picture
Table Merck Serono Lung Cancer Therapeutics Product Specification
Table 2010-2015 Merck Serono Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Merck Serono Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Merck Serono Lung Cancer Therapeutics Product Production Global Market Share
Figure Novartis Lung Cancer Therapeutics Product Picture
Table Novartis Lung Cancer Therapeutics Product Specification
Table 2010-2015 Novartis Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Novartis Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Novartis Lung Cancer Therapeutics Product Production Global Market Share
Figure Qiagen Lung Cancer Therapeutics Product Picture
Table Qiagen Lung Cancer Therapeutics Product Specification
Table 2010-2015 Qiagen Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Qiagen Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Qiagen Lung Cancer Therapeutics Product Production Global Market Share
Figure OncoGenex Lung Cancer Therapeutics Product Picture
Table OncoGenex Lung Cancer Therapeutics Product Specification
Table 2010-2015 OncoGenex Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 OncoGenex Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 OncoGenex Lung Cancer Therapeutics Product Production Global Market Share
Figure OSI Pharmaceuticals Lung Cancer Therapeutics Product Picture
Table OSI Pharmaceuticals Lung Cancer Therapeutics Product Specification
Table 2010-2015 OSI Pharmaceuticals Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 OSI Pharmaceuticals Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 OSI Pharmaceuticals Lung Cancer Therapeutics Product Production Global Market Share
Figure Peregrine Lung Cancer Therapeutics Product Picture
Table Peregrine Lung Cancer Therapeutics Product Specification
Table 2010-2015 Peregrine Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Peregrine Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Peregrine Lung Cancer Therapeutics Product Production Global Market Share
Figure Pierre Fabre Lung Cancer Therapeutics Product Picture
Table Pierre Fabre Lung Cancer Therapeutics Product Specification
Table 2010-2015 Pierre Fabre Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Pierre Fabre Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Fi

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Lung Cancer: Analytical Tool

Lung Cancer: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Market Access Impact: Non-Small Cell Lung Cancer (EU5) 2016

Market Access Impact: Non-Small Cell Lung Cancer (EU5) 2016

  • $ 5390
  • Industry report
  • September 2016
  • by Firstword Pharma

Prescription barriers hurt 5 of the 9 brands we surveyed. Is your brand losing market share? In the EU5, one of the most prescribed NSCLC drugs is stuck in 2nd place due to the biggest barrier-related ...

Market Access Impact: Non-Small Cell Lung Cancer (US) 2016

Market Access Impact: Non-Small Cell Lung Cancer (US) 2016

  • $ 5390
  • Industry report
  • September 2016
  • by Firstword Pharma

7 of the 10 brands we surveyed lose share due to market barriers. Is your brand one of them? In the US, market barriers are causing 7 of the 10 NSCLC drugs we surveyed to lose market share. What’s ...


Download Unlimited Documents from Trusted Public Sources

Cancer Statistics in the UK

  • December 2016
    20 pages
  • Cancer  

  • United Kingdom  

    Europe  

View report >

Cancer Statistics in the US

  • December 2016
    112 pages
  • Cancer  

  • United States  

    North America  

View report >

Cancer Statistics in the UK

  • November 2016
    10 pages
  • Cancer  

  • United Kingdom  

View report >

Related Market Segments :

Lung Cancer

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.